We used shRNA-mediated gene knockdown to deplete ASPP2 or HMGCR expression in breast cancer cells MDA-MB-231 and 4T1 to generate cancer cells with enhanced or decreased cholesterol biosynthesis. The gene discussed is TP53BP2; the disease is breast carcinoma.